Mark Sabag sold $1.9M of TEVA stock
By AlphaYouPublished Form 4
Sabag Mark
Reporting filer
Mark Sabag reported selling 46,000 shares of Teva Pharmaceutical Industries Ltd for about $1.9M ($41.93 a share on average). Form 4 filed Nov 6, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Nov 6, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sabag Mark | 2026-11-05 | M | Exercise or conversion | 46000 | 34.9 | 126,760 | 1 day | Filed terms
|
| Ordinary Shares | Sabag Mark | 2026-11-05 | S | Sale | 46000 | 41.9289 | 80,760 | 1 day | Filed terms
|
| Stock Options (right to buy) (derivative) | Sabag Mark | 2026-11-05 | M | Exercise or conversion | 46000 | 0 | 44,710 | 1 day | Filed terms
|
Ordinary Shares
- Owner
- Sabag Mark
- Date
- 2026-11-05
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 46000
- Price
- 34.9
- Following holdings
- 126,760
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-11-05
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 46000
- transaction Price Per Share: 34.9
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 126760
- direct Or Indirect Ownership: D
Ordinary Shares
- Owner
- Sabag Mark
- Date
- 2026-11-05
- Code
- S
- Action
- Sale
- Quantity
- 46000
- Price
- 41.9289
- Following holdings
- 80,760
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-11-05
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- transaction Shares: 46000
- transaction Price Per Share: 41.9289
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 80760
- direct Or Indirect Ownership: D
Stock Options (right to buy) (derivative)
- Owner
- Sabag Mark
- Date
- 2026-11-05
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 46000
- Price
- 0
- Following holdings
- 44,710
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Options (right to buy)
- conversion Or Exercise Price: 34.9
- transaction Date: 2026-11-05
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 46000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2027-02-14
- underlying Security Title: Ordinary Shares
- underlying Security Shares: 46000
- shares Owned Following Transaction: 44710
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sabag Mark: See "Remarks".
- F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.81 to $42.08, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2: Stock options were granted on February 14, 2017, with 30,236 vested on each of February 14, 2018, February 14, 2019 and February 14, 2020, and 30,238 vested on February 14, 2021.
Original sources
Prepared automatically from public filing data. Report a correction.